Belon P, Cumps J, Ennis M, Mannaioni P F, Roberfroid M, Sainte-Laudy J, Wiegant F A C
Boiron, 20 rue de la Libération, 69110 Sainte-Foy-Les-Lyon, France.
Inflamm Res. 2004 May;53(5):181-8. doi: 10.1007/s00011-003-1242-0. Epub 2004 Apr 21.
In order to demonstrate that high dilutions of histamine are able to inhibit basophil activation in a reproducible fashion, several techniques were used in different research laboratories.
The aim of the study was to investigate the action of histamine dilutions on basophil activation.
Basophil activation was assessed by alcian blue staining, measurement of histamine release and CD63 expression. Study 1 used a blinded multi-centre approach in 4 centres. Study 2, related to the confirmation of the multi-centre study by flow cytometry, was performed independently in 3 laboratories. Study 3 examined the histamine release (one laboratory) and the activity of H(2) receptor antagonists and structural analogues (two laboratories).
High dilutions of histamine (10(-30)-10(-38) M) influence the activation of human basophils measured by alcian blue staining. The degree of inhibition depends on the initial level of anti-IgE induced stimulation, with the greatest inhibitory effects seen at lower levels of stimulation. This multicentre study was confirmed in the three laboratories by using flow cytometry and in one laboratory by histamine release. Inhibition of CD63 expression by histamine high dilutions was reversed by cimetidine (effect observed in two laboratories) and not by ranitidine (one laboratory). Histidine tested in parallel with histamine showed no activity on this model.
In 3 different types of experiment, it has been shown that high dilutions of histamine may indeed exert an effect on basophil activity. This activity observed by staining basophils with alcian blue was confirmed by flow cytometry. Inhibition by histamine was reversed by anti-H2 and was not observed with histidine these results being in favour of the specificity of this effect We are however unable to explain our findings and are reporting them to encourage others to investigate this phenomenon.
为了证明组胺的高稀释液能够以可重复的方式抑制嗜碱性粒细胞的活化,不同的研究实验室采用了多种技术。
本研究旨在探讨组胺稀释液对嗜碱性粒细胞活化的作用。
通过阿尔辛蓝染色、组胺释放量测定和CD63表达来评估嗜碱性粒细胞的活化。研究1在4个中心采用了盲法多中心研究方法。研究2是通过流式细胞术对多中心研究进行确认,在3个实验室独立进行。研究3检测了组胺释放(1个实验室)以及H2受体拮抗剂和结构类似物的活性(2个实验室)。
组胺的高稀释液(10^(-30)-10^(-38)M)会影响通过阿尔辛蓝染色测定的人嗜碱性粒细胞的活化。抑制程度取决于抗IgE诱导刺激的初始水平,在较低刺激水平时观察到最大抑制作用。这项多中心研究在3个实验室通过流式细胞术得到了证实,在1个实验室通过组胺释放得到了证实。组胺高稀释液对CD63表达的抑制作用可被西咪替丁逆转(在2个实验室观察到该效应),而雷尼替丁则不能(1个实验室)。与组胺平行检测的组氨酸在该模型上无活性。
在3种不同类型的实验中,已表明组胺的高稀释液确实可能对嗜碱性粒细胞活性产生影响。通过用阿尔辛蓝对嗜碱性粒细胞染色观察到的这种活性通过流式细胞术得到了证实。组胺的抑制作用可被抗H2药物逆转,而组氨酸未观察到这种作用,这些结果支持了这种效应的特异性。然而,我们无法解释我们的发现,现报告这些结果以鼓励其他人研究这一现象。